Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Treatment recommendations from the Eighth International Workshop on Waldenström’s Macroglobulinemia

Véronique Leblond, Efstathios Kastritis, Ranjana Advani, Stephen M. Ansell, Christian Buske, Jorge J. Castillo, Ramón García-Sanz, Morie Gertz, Eva Kimby, Charalampia Kyriakou, Giampaolo Merlini, Monique C. Minnema, Pierre Morel, Enrica Morra, Mathias Rummel, Ashutosh Wechalekar, Christopher J. Patterson, Steven P. Treon, Meletios A. Dimopoulos

Blood (2016) 128 (10): 1321–1328.

https://doi.org/10.1182/blood-2016-04-711234

Published: 2016

Journal Articles

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

Anita D'Souza, Martha Lacy, Morie Gertz, Shaji Kumar, Francis Buadi, Suzanne Hayman, David Dingli, Steven Zeldenrust, Robert Kyle, Stephen Ansell, David Inwards, Patrick Johnston, Ivana Micallef, Luis Porrata, Mark Litzow, Dennis Gastineau, William Hogan, Angela Dispenzieri

Blood (2012) 120 (1): 56–62.

https://doi.org/10.1182/blood-2012-04-423178

Published: 2012

Journal Articles

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3

Blood (2011) 117 (18): 4701–4705.

https://doi.org/10.1182/blood-2010-10-299529

Published: 2011

Journal Articles

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Nelson Leung, MD, Shaji Kumar, MD, Angela Dispenzieri, M.D., Martha Lacy, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Dennis Gastineau, MD, Morie Gertz, MD

Blood (2010) 116 (21): 3572.

https://doi.org/10.1182/blood.V116.21.3572.3572

Published: 2010

Journal Articles

Role of Hepcidin In Anemia of Waldenström Macroglobulinemia

Madappa N. Kundranda, MD, PhD, Travis J Henry, Ph.D, Angela Dispenzieri, MD, Morie Gertz, MD, Stephen M. Ansell, MD, PhD, Rafael Fonseca, MD

Blood (2010) 116 (21): 4984.

https://doi.org/10.1182/blood.V116.21.4984.4984

Published: 2010

Journal Articles

Unraveling Early Mortality In Patients with AL Amyloidosis

Cheng E. Chee, MD, Vincent Rajkumar, PhD, Morie Gertz, Martha Lacy, MD, Steven Zeldenrust, Shaji Kumar, MD, Suzanne R. Hayman, MD, Francis Buadi, MB, CHB, Stephen Russell, MD, PhD, Robert Kyle, MD, Philip R. Greipp, MD, Angela Dispenzieri, M.D.

Blood (2010) 116 (21): 4990.

https://doi.org/10.1182/blood.V116.21.4990.4990

Published: 2010

Journal Articles

Pre-Stem Cell Transplant Induction Therapy Does Not Affect Post-Transplant Survival In Light Chain (AL) Amyloidosis

Sumit Madan, MD, Shaji Kumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Francis Buadi, MD, Suzanne R. Hayman, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Morie Gertz, MD

Blood (2010) 116 (21): 370.

https://doi.org/10.1182/blood.V116.21.370.370

Published: 2010

Journal Articles

Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma

Sumit Madan, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Morie Gertz, MD, Francis Buadi, MD, Suzanne R. Hayman, MD, Kristen Detweiler-Short, David Dingli, M.D., Ph.D., Steven Zeldenrust, MD, John Lust, MD, PhD, Philip R. Greipp, MD, S. Vincent Rajkumar, MD, Shaji Kumar, MD

Blood (2010) 116 (21): 1964.

https://doi.org/10.1182/blood.V116.21.1964.1964

Published: 2010

Journal Articles

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Kristen Detweiler Short, RN, CNP, Joseph Mikhael, MD, Angela Dispenzieri, MD, Morie Gertz, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Martha Lacy, MD

Blood (2010) 116 (21): 1965.

https://doi.org/10.1182/blood.V116.21.1965.1965

Published: 2010

Journal Articles

Recent Improvements In Survival In Light Chain Amyloidosis and the Importance of An Early Mortality Risk Score

Shaji Kumar, MD, Morie Gertz, MD, Martha Lacy, MD, David Dingli, MD, PhD, Suzanne R. Hayman, MD, Francis Buadi, MD, Kristen Detweiler-Short, Steven Zeldenrust, MD, Nelson Leung, MD, Philip R. Greipp, MD, John Lust, MD, PhD, Stephen Russell, MD, PhD, Robert Kyle, MD, Vincent Rajkumar, Angela Dispenzieri, MD

Blood (2010) 116 (21): 1892.

https://doi.org/10.1182/blood.V116.21.1892.1892

Published: 2010

Journal Articles

Improvement In Renal Function In Newly Diagnosed Myeloma Improves Survival, but Still Remains Inferior to Those with Normal Renal Function

Shaji Kumar, MD, Angela Dispenzieri, M.D., Martha Lacy, MD, Suzanne R. Hayman, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Kristen Detweiler-Short, RN, John Lust, Steven Zeldenrust, MD, Stephen Russell, MD, PhD, Philip R. Greipp, MD, Robert Kyle, MD, Morie Gertz, MD, Vincent Rajkumar

Blood (2010) 116 (21): 2970.

https://doi.org/10.1182/blood.V116.21.2970.2970

Published: 2010

Journal Articles

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

Shirshendu Sinha, MBBS, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Francis Buadi, MD, David Dingli, MD, Ph.D., Ivana Micallef, MD, William Hogan, MBBCh, Dennis Gastineau, MD, S. Vincent Rajkumar, MD, Shaji Kumar, MD

Blood (2010) 116 (21): 2253.

https://doi.org/10.1182/blood.V116.21.2253.2253

Published: 2010

Journal Articles

Five-Year Follow-up of Randomized, Phase II Trial of Idiotype-Pulsed Dendritic Cell Vaccine with Adjuvant Cytokines In Plateau Phase and Post-Transplant Multiple Myeloma

Yi Lin, MDPhD, Morie Gertz, MD, Sumithra Mandrekar, PhD, Kristina Laumann, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Douglas Padley, Dennis Gastineau, MD, Shaji Kumar, MD, Vincent Rajkumar, Martha Lacy, MD

Blood (2010) 116 (21): 1958.

https://doi.org/10.1182/blood.V116.21.1958.1958

Published: 2010

Journal Articles

A Risk Adapted Approach Utilizing Plerixafor in Autologous Peripheral Blood Stem Cell Mobilization.

Ivana Micallef, Stephen M Ansell, Francis Buadi, David Dingli, M.D., PhD., Angela Dispenzieri, Dennis Gastineau, Morie Gertz, Suzanne R. Hayman, MD, William Hogan, MD, David J Inwards, Patrick L Johnston, MD, PhD, Shaji Kumar, MD, Martha Q. Lacy, MD, Mark R. Litzow, MD, Luis Porrata, MD, Robert Wolf, PharmD, Teresa Miceli, Jeff Winters

Blood (2009) 114 (22): 3211.

https://doi.org/10.1182/blood.V114.22.3211.3211

Published: 2009

Journal Articles

Depth of Response with Stem Cell Transplantation and Outcome for Multiple Myeloma in the Era of Novel Agents.

David Dingli, M.D., Ph.D., Francesca Gay, MD, Francis Buadi, MD, Angela Dispenzieri, MD, Suzanne R Hayman, MD, Shaji Kumar, MD, Martha Q. Lacy, MD, Stephen J. Russell, MD, PhD, Vincent Rajkumar, MD, Morie Gertz, MD

Blood (2009) 114 (22): 1228.

https://doi.org/10.1182/blood.V114.22.1228.1228

Published: 2009

Journal Articles

Lenalidomide Plus Dexamethasone Versus Lenalidomide Plus Melphalan and Prednisone: A Case-Control Study in Newly Diagnosed Elderly Myeloma Patients.

Blood (2009) 114 (22): 2877.

https://doi.org/10.1182/blood.V114.22.2877.2877

Published: 2009

Journal Articles

Finishing off fibrils

Morie Gertz

Blood (2009) 114 (8): 1456–1457.

https://doi.org/10.1182/blood-2009-06-228411

Published: 2009

Journal Articles

Survival in Patients with Newly Diagnosed Myeloma Undergoing Therapy with Lenalidomide and Dexamethasone: Impact of High-Risk Cytogenetic Risk Status on Outcome

Blood (2008) 112 (11): 95.

https://doi.org/10.1182/blood.V112.11.95.95

Published: 2008

Journal Articles

Phase II Trial of Lenalidomide (Revlimid ™ ) with Cyclophosphamide and Dexamethasone (RCd) for Newly Diagnosed Myeloma

Blood (2008) 112 (11): 91.

https://doi.org/10.1182/blood.V112.11.91.91

Published: 2008

Journal Articles

Serum Immunoglobulin Free Light Chain in Primary Amyloidosis: Prognostic Value and Correlations with Clinical Features

Shaji Kumar, MD, Angela Dispenzieri, Raynell Clark, Dirk Larson, Colin Colby, Steve Zeldenrust, Martha Lacy, Suzzane Hayman, Francis Buadi, Nelson Leung, Marina Ramirez-Alvarado, Robert Kyle, Jerry Katzmann, S. Vincent Rajkumar, Morie Gertz

Blood (2008) 112 (11): 2733.

https://doi.org/10.1182/blood.V112.11.2733.2733

Published: 2008

NARROW

Treatment recommendations from the Eighth International Workshop on Waldenström’s Macroglobulinemia

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Role of Hepcidin In Anemia of Waldenström Macroglobulinemia

Unraveling Early Mortality In Patients with AL Amyloidosis

Pre-Stem Cell Transplant Induction Therapy Does Not Affect Post-Transplant Survival In Light Chain (AL) Amyloidosis

Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Recent Improvements In Survival In Light Chain Amyloidosis and the Importance of An Early Mortality Risk Score

Improvement In Renal Function In Newly Diagnosed Myeloma Improves Survival, but Still Remains Inferior to Those with Normal Renal Function

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

Five-Year Follow-up of Randomized, Phase II Trial of Idiotype-Pulsed Dendritic Cell Vaccine with Adjuvant Cytokines In Plateau Phase and Post-Transplant Multiple Myeloma

A Risk Adapted Approach Utilizing Plerixafor in Autologous Peripheral Blood Stem Cell Mobilization.

Depth of Response with Stem Cell Transplantation and Outcome for Multiple Myeloma in the Era of Novel Agents.

Lenalidomide Plus Dexamethasone Versus Lenalidomide Plus Melphalan and Prednisone: A Case-Control Study in Newly Diagnosed Elderly Myeloma Patients.

Finishing off fibrils

Survival in Patients with Newly Diagnosed Myeloma Undergoing Therapy with Lenalidomide and Dexamethasone: Impact of High-Risk Cytogenetic Risk Status on Outcome

Phase II Trial of Lenalidomide (Revlimid ™ ) with Cyclophosphamide and Dexamethasone (RCd) for Newly Diagnosed Myeloma

Serum Immunoglobulin Free Light Chain in Primary Amyloidosis: Prognostic Value and Correlations with Clinical Features

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only